Literature DB >> 12186501

Iodine deficiency in Azerbaijan after the discontinuation of an iodine prophylaxis program: reassessment of iodine intake and goiter prevalence in schoolchildren.

K B Markou1, N A Georgopoulos, M Makri, E Anastasiou, B Vlasopoulou, N Lazarou, L Deville, C Megreli, G A Vagenakis, G C Sakellaropoulos, R Jabbarov, M G Kerimova, R M Mamedgasanov, A G Vagenakis.   

Abstract

The goal of this study was to assess the prevalence of iodine deficiency (ID) in Azerbaijan after the discontinuation of an iodine prophylaxis program by assessing the prevalence of goiter, iodine intake, and thyroid function. The study included 942 schoolchildren (475 boys and 467 girls) ages 8-14 years, from 13 distinct regions. The survey included the following: (1) clinical evaluation; (2) assessment of thyroid volume both by ultrasound and by palpation; (3) determination of iodide in a morning urine specimen using the classic Sandel-Kolthoff reaction in 347 schoolchildren; (4) determinations of thyrotropin (TSH), triiodothyronine (T3), thyroxine (T4), thyroglobulin (Tg), and anti-thyroid peroxidase (TPO) in serum (n = 165) and TSH in whole blood spotted on filter paper (n = 942). The prevalence of goiter for the whole country was determined by ultrasound (US) to be 86% and by palpation 66%, reaching 100% in the mountainous regions of Caucasus. The median urinary iodine excretion (UIE) was 54 microg/L, reaching level of 26 and 39 microg/L in the Caucasus region. In conclusion, according to the World Health Organization (WHO) classification, Azerbaijan now has mild to moderate ID (median UIE, 54 microg/L) and in the mountainous regions with severe ID. The high prevalence of goiter and the low UIE emphasizes the need for urgent medical reintervention. An iodination program is now implemented by our team in the mountainous regions under the auspice of the government of Azerbaijan.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12186501     DOI: 10.1089/10507250152740984

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  6 in total

1.  Differences between subjects with sufficient and deficient urinary iodine in an area of iodine sufficiency.

Authors:  P Nazeri; P Mirmiran; G Asghari; H Delshad; Y Mehrabi; M Hedayati; F Azizi
Journal:  J Endocrinol Invest       Date:  2011-07-05       Impact factor: 4.256

2.  Iodized salt in Cambodia: trends from 2008 to 2014.

Authors:  Arnaud Laillou; Borath Mam; Sam Oeurn; Chantum Chea
Journal:  Nutrients       Date:  2015-05-29       Impact factor: 5.717

3.  Low Urinary Iodine Concentration among Mothers and Children in Cambodia.

Authors:  Arnaud Laillou; Prak Sophonneary; Khov Kuong; Rathavuth Hong; Samoeurn Un; Chhoun Chamnan; Etienne Poirot; Jacques Berger; Frank Wieringa
Journal:  Nutrients       Date:  2016-04-05       Impact factor: 5.717

4.  Stable Iodine Nutrition During Two Decades of Continuous Universal Salt Iodisation in Sri Lanka.

Authors:  Renuka Jayatissa; Jonathan Gorstein; Onyebuchi E Okosieme; John H Lazarus; Lakdasa D Premawardhana
Journal:  Nutrients       Date:  2020-04-16       Impact factor: 5.717

5.  Continuously sustained elimination of iodine deficiency: a quarter of a century success in the Islamic Republic of Iran.

Authors:  H Delshad; P Mirmiran; Z Abdollahi; F Salehi; F Azizi
Journal:  J Endocrinol Invest       Date:  2018-02-14       Impact factor: 4.256

6.  Iodine deficiency disorders (IDD) control in India.

Authors:  Chandrakant S Pandav; Kapil Yadav; Rahul Srivastava; Rijuta Pandav; M G Karmarkar
Journal:  Indian J Med Res       Date:  2013-09       Impact factor: 2.375

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.